Incorporating data from various trial designs into a mixed treatment comparison model

Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study

(2014) Nobuyuki Miyasaka et al.   Modern Rheumatology

A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach

(2011) Susanne Schmitz et al.   ANNALS OF THE RHEUMATIC DISEASES

A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis

(2011) E. Turkstra et al.   CURRENT MEDICAL RESEARCH AND OPINION

Comparison of Certolizumab Pegol with Other Anticytokine Agents for Treatment of Rheumatoid Arthritis: A Multiple-treatment Bayesian Metaanalysis

(2011) ROBERT LAUNOIS et al.   JOURNAL OF RHEUMATOLOGY

How Valuable are Multiple Treatment Comparison Methods in Evidence-Based Health-Care Evaluation?

(2011) Nicola J. Cooper et al.   VALUE IN HEALTH

Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach

(2010) Emily Beth Devine et al.   PHARMACOTHERAPY

Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs

(2010) Gert J.D. Bergman et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Checking consistency in mixed treatment comparison meta-analysis

(2010) S. Dias et al.   STATISTICS IN MEDICINE

Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women

(2009) Shelley R. Salpeter et al.   AMERICAN JOURNAL OF MEDICINE

Rheumatoid arthritis

(2009) Lars Klareskog et al.   LANCET

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

(2008) J Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

(2008) R Fleischmann et al.   ANNALS OF THE RHEUMATIC DISEASES

Golimumab, a human antibody to tumour necrosis factor   given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

(2008) E C Keystone et al.   ANNALS OF THE RHEUMATIC DISEASES

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

(2008) Edward Keystone et al.   ARTHRITIS AND RHEUMATISM

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Anti-TNFα therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes

(2008) Chiara Bazzani et al.   AUTOIMMUNITY REVIEWS

Models for potentially biased evidence in meta-analysis using empirically based priors

(2008) N. J. Welton et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

Bias modelling in evidence synthesis

(2008) Rebecca M. Turner et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

Mixed treatment comparison with multiple outcomes reported inconsistently across trials: Evaluation of antivirals for treatment of influenza A and B

(2008) N. J. Welton et al.   STATISTICS IN MEDICINE

Recent developments in meta-analysis

(2007) Alexander J. Sutton et al.   STATISTICS IN MEDICINE